DaVita
DVA
#2255
Rank
S$10.49 B
Marketcap
S$146.85
Share price
-0.27%
Change (1 day)
-30.36%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): S$13.10

According to DaVita's latest financial reports the company's current EPS (TTM) is S$12.76. In 2024 the company made an earnings per share (EPS) of S$14.16 an increase over its 2023 EPS that were of S$9.77.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$13.10-7.45%
2024S$14.1644.94%
2023S$9.7727.26%
2022S$7.68-35.56%
2021S$11.9144.1%
2020S$8.2719.7%
2019S$6.91540.48%
2018S$1.08-76.07%
2017S$4.51-19.31%
2016S$5.58242.52%
2015S$1.63-62.87%
2014S$4.3913.43%
2013S$3.878.45%
2012S$3.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
S$18.87 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.44-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
S$27.40 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$13.16 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA